Measuring recovery in health-related quality of life during and after pulmonary exacerbations in patients with cystic fibrosis

Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del<i>CFTR</i>

Claire Wainwright, J.S. Elborn, Bonnie W. Ramsey et al. · New England Journal of Medicine · 2015 · 1.6K citations · Full text

Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic Fibrosis

Henry J. Fuchs, Drucy Borowitz, David Høyrup Christiansen et al. · New England Journal of Medicine · 1994 · 1.5K citations · Full text

Predictive 5-Year Survivorship Model of Cystic Fibrosis

Theodore G. Liou, Frederick R. Adler, Stacey C. FitzSimmons et al. · American Journal of Epidemiology · 2001 · 721 citations · Full text

Lung Transplantation, Disease Progression, Stress +8

Failure to Recover to Baseline Pulmonary Function after Cystic Fibrosis Pulmonary Exacerbation

Don B. Sanders, Rachel Bittner, Margaret Rosenfeld et al. · American Journal of Respiratory and Critical Care Medicine · 2010 · 514 citations · Full text

Impact of Recent Pulmonary Exacerbations on Quality of Life in Patients With Cystic Fibrosis

Maria T. Britto, Uma R. Kotagal, Richard Hornung et al. · CHEST Journal · 2002 · 345 citations

Pulmonary Care, Inflammatory Lung Disease, Advanced Lung Disease +7